Literature DB >> 2360176

Axillary node dissection in malignant melanoma: results and complications.

C P Karakousis1, M A Hena, L J Emrich, D L Driscoll.   

Abstract

Axillary node dissection was performed in 133 patients with malignant melanoma. The nodes were histologically negative for disease in 67 patients and positive in 66 patients. Disease-free survival rate varied according to the histologic and clinical status of the nodes and to the number of the nodes involved by tumor. The lymphocele rate was 7%; the wound infection rate was 5%; and the skin edge necrosis rate was 0.8%. One patient (0.8%) experienced both lymphocele and wound infection. Neurapraxia developed in the distribution of the musculocutaneous nerve in two patients (2%); this resolved completely in 3 to 4 weeks and was not observed again, since hyperextension of the arm has been carefully avoided during the procedure. Transient arm edema was noted postoperatively in five patients (4%), and the edema responded promptly and completely to elevation of the arm for 1 to 2 weeks. There was no permanent edema even after ligation and resection of the distal portion of the axillary vein (six patients). Permanent arm edema has not developed in any of the 133 patients, indicating that axillary node dissection as performed for malignant melanoma is not associated with the long-term complications occurring after mastectomy and axillary node dissection.

Entities:  

Mesh:

Year:  1990        PMID: 2360176

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM.

Authors:  F Egberts; C Hartje; C Schafmayer; K C Kaehler; W von Schönfels; A Hauschild; T Becker; J H Egberts
Journal:  Ann R Coll Surg Engl       Date:  2011-10       Impact factor: 1.891

2.  [Axillary lymph node dissection in malignant melanoma].

Authors:  P Hohenberger
Journal:  Langenbecks Arch Chir       Date:  1993

Review 3.  Elective lymph node dissection for melanoma: two perspectives.

Authors:  W H McCarthy; H M Shaw; N Cascinelli; M Santinami; F Belli
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

4.  Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition.

Authors:  Emma C Starritt; David Joseph; J Gregory McKinnon; Sing Kai Lo; Johannes H W de Wilt; John F Thompson
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

5.  [Axillar lymphadenectomy].

Authors:  D Oertli
Journal:  Chirurg       Date:  2007-03       Impact factor: 0.955

6.  Intraoperative application of fibrin sealant does not reduce the duration of closed suction drainage following radical axillary lymph node dissection in melanoma patients: a prospective randomized trial in 58 patients.

Authors:  Heiko Neuss; Wieland Raue; Gerold Koplin; Wolfgang Schwenk; Christian Reetz; Julian W Mall
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

7.  Adjuvant radiation therapy in metastatic lymph nodes from melanoma.

Authors:  Jean-Emmanuel Bibault; Sylvain Dewas; Xavier Mirabel; Laurent Mortier; Nicolas Penel; Luc Vanseymortier; Eric Lartigau
Journal:  Radiat Oncol       Date:  2011-02-06       Impact factor: 3.481

8.  Postoperative Complications following Nodal Dissection and Their Association with Melanoma Recurrence.

Authors:  Abubakr Ahmed; Gaitri Sadadcharam; Felicity Huisma; Katrina Fogarty; Muhammad Mushtaque; Azher Shafiq; Paul Redmond
Journal:  ISRN Surg       Date:  2013-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.